Please login to the form below

Not currently logged in

Lonely planet: why there is dwindling value in pharma travelling alone


To develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward

Accelerating diagnosis in rare disease

Gavin JonesBiopharmaceutical companies can drive effective partnerships and improve outcomes for all stakeholders and patients in the area of rare disease.

Accelerating innovation

AlexandreIpsen’s Alexandre Lebeaut on the French firm’s oncology plans, global focus and R&D approach

Opening up innovation

Paul-Peter Tak on GlaxoSmithKline’s R&D strategy and the pivotal role of immunology

Transformational technology

Big data, the cloud and the value of insights

Featured jobs

Subscribe to our email news alerts


Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...